Newman, Bianca A.
Rosebrough, Claire N.
Tamashiro, Ryan A.
Dias Ribeiro, Ana P.
Whitlock, Joan A.
Sidhu, Gurjit
Aukhil, Ikramuddin
Porral, Dianne Y.
Progulske-Fox, Ann
Myntti, Matthew F.
Wang, Gary P.
Article History
Received: 19 July 2022
Accepted: 10 October 2022
First Online: 2 November 2022
Declarations
:
: All subjects provided written informed consent to participate in the study. This study was approved by University of Florida Institutional Review Board (IRB 201700505) and registered with NIH Clinical Trials Registry on 15/05/2017 (ExternalRef removed NCT03154021). All procedures were carried out in accordance with relevant guidelines and procedures.
: Not applicable.
: Dr. Matthew Myntti is the Chief Technology Officer of Next Science and is a shareholder. Dianne Porral is a full-time employee of Next Science and is also a shareholder.